391 related articles for article (PubMed ID: 26852916)
1. Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
Lu H; Li J; Wang L; Zhou H; Liu Y; Wang D; Lin Z
Med Sci Monit; 2016 Feb; 22():408-14. PubMed ID: 26852916
[TBL] [Abstract][Full Text] [Related]
2. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
[TBL] [Abstract][Full Text] [Related]
3. Should ovaries be removed or not in early-stage cervical adenocarcinoma: a multicenter retrospective study of 105 patients.
Hu J; Jiao X; Yang Z; Cui H; Guo H; Wu Y; Zhu L
J Obstet Gynaecol; 2017 Nov; 37(8):1065-1069. PubMed ID: 28631536
[TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
[TBL] [Abstract][Full Text] [Related]
5. [Clinical analysis of ovarian metastasis in patients with Ⅰb stage cervical adenocarcinoma].
Lu H; Chen H; Liu Y; Wang D; Xu G; Lin Z
Zhonghua Yi Xue Za Zhi; 2016 Jan; 96(3):203-6. PubMed ID: 26879723
[TBL] [Abstract][Full Text] [Related]
6. Ovarian metastasis in stage IB and II cervical adenocarcinoma.
Natsume N; Aoki Y; Kase H; Kashima K; Sugaya S; Tanaka K
Gynecol Oncol; 1999 Aug; 74(2):255-8. PubMed ID: 10419741
[TBL] [Abstract][Full Text] [Related]
7. Ovarian metastasis in carcinoma of the uterine cervix.
Shimada M; Kigawa J; Nishimura R; Yamaguchi S; Kuzuya K; Nakanishi T; Suzuki M; Kita T; Iwasaka T; Terakawa N
Gynecol Oncol; 2006 May; 101(2):234-7. PubMed ID: 16300819
[TBL] [Abstract][Full Text] [Related]
8. Risk factors of pelvic lymph node metastasis in cervical adenocarcinoma following radical hysterectomy and pelvic lymphadenectomy.
Yanaranop M; Sathapornteera N; Nakrangsee S
J Med Assoc Thai; 2014 Nov; 97 Suppl 11():S87-95. PubMed ID: 25509701
[TBL] [Abstract][Full Text] [Related]
9. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
[TBL] [Abstract][Full Text] [Related]
10. Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: a review.
Touhami O; Plante M
Gynecol Oncol; 2015 Feb; 136(2):384-8. PubMed ID: 25511157
[TBL] [Abstract][Full Text] [Related]
11. Ovarian metastases from stage IB adenocarcinoma of the cervix.
Mann WJ; Chumas J; Amalfitano T; Westermann C; Patsner B
Cancer; 1987 Sep; 60(5):1123-6. PubMed ID: 3607729
[TBL] [Abstract][Full Text] [Related]
12. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
[TBL] [Abstract][Full Text] [Related]
13. Independent risk factors for ovarian metastases in stage IA-IIB cervical carcinoma.
Zhou L; Sun CT; Lin L; Xie Y; Huang Y; Li Q; Liu X
Acta Obstet Gynecol Scand; 2019 Jan; 98(1):18-23. PubMed ID: 30129170
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological risk factors for pelvic lymph node metastasis in clinical early-stage endometrioid endometrial adenocarcinoma.
Zhang C; Wang C; Feng W
Int J Gynecol Cancer; 2012 Oct; 22(8):1373-7. PubMed ID: 22932266
[TBL] [Abstract][Full Text] [Related]
15. Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
Sutton GP; Bundy BN; Delgado G; Sevin BU; Creasman WT; Major FJ; Zaino R
Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):50-3. PubMed ID: 1733218
[TBL] [Abstract][Full Text] [Related]
16. Microscopic ovarian metastasis of the uterine cervical cancer.
Toki N; Tsukamoto N; Kaku T; Toh N; Saito T; Kamura T; Matsukuma K; Nakano H
Gynecol Oncol; 1991 Apr; 41(1):46-51. PubMed ID: 2026359
[TBL] [Abstract][Full Text] [Related]
17. The potential for less radical surgery in women with stage IA2-IB1 cervical cancer.
Bai H; Yuan F; Wang H; Chen J; Cui Q; Shen K
Int J Gynaecol Obstet; 2015 Sep; 130(3):235-40. PubMed ID: 26070225
[TBL] [Abstract][Full Text] [Related]
18. Do FIGO stage IA and small (≤2 cm) IB1 cervical adenocarcinomas have a good prognosis and warrant less radical surgery?
Al-Kalbani M; McVeigh G; Nagar H; McCluggage WG
Int J Gynecol Cancer; 2012 Feb; 22(2):291-5. PubMed ID: 22080884
[TBL] [Abstract][Full Text] [Related]
19. Identifying a candidate population for ovarian conservation in young women with clinical stage IB-IIB cervical cancer.
Matsuo K; Shimada M; Yamaguchi S; Kanao H; Nakanishi T; Saito T; Kamiura S; Iwata T; Mikami M; Sugiyama T
Int J Cancer; 2018 Mar; 142(5):1022-1032. PubMed ID: 28975603
[TBL] [Abstract][Full Text] [Related]
20. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
